On 26th January 2022, Vitaccess hosted the fourth webinar in the “Keeping it real” series.
Dr Mark Larkin, Founder and CEO of Vitaccess, and Sam Llewellyn, Senior Consultant, presented a webinar on adding safety reporting to create continuous pre- to post-approval longitudinal digital RWE studies. Joining them was special guest Esther Daemen, Senior Clinical Research, Quality, Regulatory, and GDPR Consultant in the pharma and biotech industries.
They looked at how the use of digital tools means that longitudinal RWE studies can be considered as adaptive registries, with a powerful range of both pre- and post-approval use cases.
You can also read our blog about adding safety reporting to create continuous pre- to post-approval longitudinal digital real-world evidence studies by clicking here.